Ayahuasca: Pharmacological Composition and Potential Benefits
Raj Nashikkar, Shrikrishna Baokar, Rajendra Patil
Research Journal of Pharmacy and Technology October 1, 2025 DOI: 10.52711/0974-360x.2025.00731 via OpenAlex
Summary
AI-generated from the abstractAyahuasca, a traditional hallucinogenic brew from the Amazon Basin, combines the Banisteriopsis caapi vine and Psychotria viridis leaves. Its psychoactive effect relies on DMT, a hallucinogen from Psychotria viridis, which is normally broken down by monoamine oxidase enzymes in the body. Beta-carbolines from Banisteriopsis caapi inhibit these enzymes, allowing DMT to reach the brain and produce vivid hallucinations, emotional sensitivity, and altered consciousness. Scientific research explores its psychological benefits, including emotional healing through introspection and trauma processing, with promising applications for depression, anxiety, and PTSD. The brew may also enhance neural plasticity, helping individuals overcome negative thought patterns.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Ayahuasca |
| Key finding | Ayahuasca's psychoactive effect depends on beta-carbolines inhibiting MAO enzymes to allow orally inactive DMT to reach the brain, producing extended psychedelic experiences, and preliminary research suggests potential therapeutic benefits for depression, anxiety, and PTSD by promoting emotional healing and neural plasticity. |
Abstract
Ayahuasca is a traditional hallucinogenic concoction utilised by indigenous populations in the Amazon Basin for ages in spiritual and therapeutic rituals. The increasing global popularity is attributed to its alleged medicinal and consciousness-expanding properties. The infusion is primarily composed of two key components: the Banisteriopsis caapi vine and the leaves of Psychotria viridis, which collectively yield the intended psychoactive effect. The pharmacological composition of Ayahuasca is based on the interaction between N, N-dimethyltryptamine (DMT), a powerful hallucinogen present in Psychotria viridis, and beta-carbolines, such as harmine, harmaline, and tetrahydroharmine, derived from Banisteriopsis caapi. DMT is not orally active due to its rapid metabolism by the body's monoamine oxidase (MAO) enzymes. The beta-carbolines in the Banisteriopsis caapi vine function as MAO inhibitors, inhibiting the degradation of DMT and facilitating its access to the brain. This leads to an extended psychedelic experience marked by vivid hallucinations, increased emotional sensitivity, and altered states of consciousness. The psychological advantages of Ayahuasca are increasingly being explored in scientific studies. Numerous individuals assert that Ayahuasca promotes emotional healing by facilitating profound introspection and the processing of unresolved trauma. This has resulted in encouraging research into its application in treating diseases such as depression, anxiety, and PTSD. The beverage's capacity to enhance neuronal connections, referred to as neural plasticity, may assist individuals in overcoming detrimental thought habits and embracing more constructive emotional reactions.